Additive effect of ketoconazole and octreotide in the treatment of severe adrenocorticotropin-dependent hypercortisolism

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 8, 1996, Pages 2885-2890

  Vignati, Federico ^a   Loli, Paola ^a  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; HYDROCORTISONE; KETOCONAZOLE; OCTREOTIDE;

ADRENALECTOMY; ADULT; ARTICLE; CASE REPORT; CORTICOTROPIN BLOOD LEVEL; CUSHING DISEASE; DRUG EFFICACY; DRUG POTENTIATION; FEMALE; HUMAN; HYDROCORTISONE URINE LEVEL; HYPERCORTISOLISM; MALE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ADRENOCORTICOTROPIC HORMONE; ADULT; DRUG SYNERGISM; FEMALE; HUMANS; HYDROCORTISONE; KETOCONAZOLE; MALE; MIDDLE AGED; OCTREOTIDE; TREATMENT OUTCOME;

EID: 0029788038     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.8.2885     Document Type: Article

References (23)

1. Howlett TA, Drury PL, Perry L, Doniach I, Rees LH, Besser GM. 1986 Diagnosis and management of ACTH-dependent Cushing's syndrome: comparison of the features in ectopic and pituitary ACTH production. Clin Endocrinol (Oxf). 24:699-713.
2. Angeli A, Frairia R. 1985 Ketoconazole therapy in Cushing's disease. Lancet 1:821.
3. Sonino N, Boscaro M, Merola G, Mantero F. 1985 Prolonged treatment of Cushing's disease by ketoconazole. J Clin Endocrinol Metab. 61:718-722.
4. Loli P, Berselli ME, Tagliaferri A. 1986 Use of ketoconazole in the treatment of Cushing's syndrome. J Clin Endocrinol Metab, 63:1365-1371.
5. Sonino N, Boscaro M, Paoletta A, Mantero F, Ziliotto D. 1991 Ketoconazole treatment in Cushing's syndrome: experience in 34 patients. Clin Endocrinol (Oxf). 35:347-352.
6. Diop SN, Warnet A, Duet M, Firmin C, Mosse A, Lubetzki J. 1989 Traitement prolongé de la maladie de Cushing par le kétoconazole. Possibilité d'un echappement thérapeutique. Presse Med. 18:1325-1328.
7. Tabarin A, Navarranne A, Guerin J, Corcuff JB, Parnelx M, Roger P. 1991 Use of ketoconazole in the treatment of Cushing's disease and ectopic ACTH syndrome. Clin Endocrinol (Oxf). 34:63-69.
8. Engelhardt D, Weber MM. 1994 Therapy of Cushing's syndrome with steroid biosynthesis inhibitors. J Steroid Biochem Mol Biol. 49:261-267.
9. Winquist EW, Laskey J, Crump M, Khamsi F, Shepherd FA. 1995 Ketoconazole in the management of paraneoplastic Cushing's syndrome secondary to ectopic adrenocorticotropic production. J Clin Oncol. 13:157-164.
10. Lamberts SWJ, Tilanus HW, Klooswijk AIJ, Bruining HA, Van Der Lely AJ, De Jong FH. 1988 Successful treatment with SMS 201-995 of Cushing's syndrome caused by ectopic adrenocorticotropin secretion from a metastatic gastrin-secreting pancreatic islet cell carcinoma. J Clin Endocrinol Metab. 67:1080-1083.
11. Bertagna X, Favrod-Coune C, Escourolle H, et al. 1989 Suppression of ectopic adrenocorticotropin secretion by the long-acting somatostatin analog Octreotide. J Clin Endocrinol Metab. 68:988-991.
12. Lamberts SWJ, Uitterlinden P, Klijn JMG. 1989 The effect of the long-acting somatostatin analogue SMS 201-995 on ACTH secretion in Nelson's syndrome and Cushing's disease. Acta Endocrinol (Copenh). 120:760-766.
13. Suzuki S, Hashizume K, Kobayashi M, et al. 1990 Somatostatin analogue (SMS 201-995) decreases plasma levels of corticotropin (ACTH) and corticotropin-releasing hormone in a patient with ectopic ACTH-producing tumors. Endocrinol Jpn. 37:923-932.
14. Invitti C, De Martin M, Brunani A, Piolini M, Cavagnini F. 1990 Treatment of Cushing's syndrome with the long-acting somatostatin analogue SMS 201-995 (sandostatin). Clin Endocrinol (Oxf). 32:275-281.
15. Kaye TB, Crapo L. 1990 The Cushing's syndrome: an update of diagnostic tests. Ann Intern Med. 112:434-444.
16. Engelhardt D, Weber MM, Miksch T, Abendipour F, Jaspers C. 1991 The influence of ketoconazole on human adrenal steroidogenesis: incubation studies with tissue slices. Clin Endocrinol (Oxf). 35:163-168.
17. Stalla GK, Stalla J, Huber M, et al. 1988 Ketoconazole inhibits corticotropic cell function in vitro. Endocrinology. 122:618-623.
18. Jimenez-Reina L, Leal-Cerro A, Garcia J, Garcia-Luna PP, Astorga R, Bernal G. 1989 In vitro effects of ketoconazole on corticotrope cell morphology and ACTH secretion of two pituitary adenomas removed from patients with Nelson's syndrome. Acta Endocrinol (Copenh). 121:185-190.
19. 2+ levels by somatostatin in human corticotropin-secreting pituitary adenomas. J Clin Endocrinol Metab. 70:1262-1268.
20. Greenman Y, Melmed S. 1994 Heterogeneous expression of two somatostatin receptor subtypes in pituitary tumors. J Clin Endocrinol Metab. 78:398-403.
21. Phlipponneau M, Nocaudie M, Epelbaum J, et al. 1994 Somatostatin analogs for the localization and preoperative treatment of an adrenocorticotropin-secreting bronchial carcinoid tumor. J Clin Endocrinol Metab. 78:20-24.
22. Lamberts SWJ, de Herder WW, Krenning EP, Reubi JC. 1994 Editorial: a role of (labeled) somatostatin analogs in the differential diagnosis and treatment of Cushing's syndrome. J Clin Endocrinol Metab. 78:17-19.
23. Stalla GK, Brockmeier SJ, Renner U. 1994 Octreotide exerts different effects in vivo and in vitro in Cushing's disease. Eur J Endocrinol. 130:125-131.